本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

68.39
-3.9900-5.51%
盤後68.390.00000.00%17:34 EDT
成交量:399.30萬
成交額:2.75億
市值:133.91億
市盈率:-19.16
高:72.41
開:72.26
低:66.96
收:72.38
52周最高:93.42
52周最低:48.78
股本:1.96億
流通股本:1.67億
量比:1.80
換手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-26.00%
市淨率:-5.32
市盈率(LYR):-18.07

資料載入中...

2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/26

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/25

SEC問詢函

[Cover]Correspondence
2019/06/24

SEC問詢函

[Cover]Correspondence
2019/06/24

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/17

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/11

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/05/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/29

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/24

招股説明書

General form for registration of securities under the Securities Act of 1933
2018/12/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2018/12/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership